Literature DB >> 3033896

Regulation of equine herpesvirus type 1 gene expression: characterization of immediate early, early, and late transcription.

W L Gray, R P Baumann, A T Robertson, G B Caughman, D J O'Callaghan, J Staczek.   

Abstract

The regulation of equine herpesvirus type 1 (EHV-1) transcription was examined in infected rabbit kidney cells using metabolic inhibitors. In order to map EHV-1 immediate early, early, and late transcripts, viral RNA was 32P-labeled in vivo and hybridized to EHV-1 DNA restriction fragments immobilized on nitrocellulose filters. Immediate early viral RNA was mapped to one region of the viral genome within the inverted repeat DNA sequences (map units 0.78-0.83 and 0.95-1.0). Northern blot hybridization analysis using a 32P-labeled cloned DNA probe from this region identified a single immediate early viral transcript (approximately 6 kb). Transcription of early and late genes was not restricted to any specific region on the viral genome as indicated by the ability of 32P-labeled early and late RNA to hybridize to EHV-1 restriction endonuclease fragments from both the long and short components of EHV-1 DNA. Additional experiments performed without the use of metabolic inhibitors confirmed that EHV-1 transcription is temporally regulated. The characterization of EHV-1 transcription during productive infection will serve as a reference for the analysis of viral transcripts in oncogenically transformed and persistently infected cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033896     DOI: 10.1016/0042-6822(87)90240-6

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  41 in total

1.  Mapping the sequences that mediate interaction of the equine herpesvirus 1 immediate-early protein and human TFIIB.

Authors:  H K Jang; R A Albrecht; K A Buczynski; S K Kim; W A Derbigny; D J O'Callaghan
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Mapping the termini and intron of the spliced immediate-early transcript of equine herpesvirus 1.

Authors:  R N Harty; C F Colle; F J Grundy; D J O'Callaghan
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

3.  Spatial and temporal distribution of bovine herpesvirus 1 transcripts.

Authors:  U V Wirth; K Gunkel; M Engels; M Schwyzer
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

4.  Characterization of cis-acting elements required for autorepression of the equine herpesvirus 1 IE gene.

Authors:  Seongman Kim; Gan Dai; Dennis J O'Callaghan; Seong Kee Kim
Journal:  Virus Res       Date:  2012-01-14       Impact factor: 3.303

5.  The early UL31 gene of equine herpesvirus 1 encodes a single-stranded DNA-binding protein that has a nuclear localization signal sequence at the C-terminus.

Authors:  Seongman Kim; Byung Chul Ahn; Dennis J O'Callaghan; Seong Kee Kim
Journal:  Virology       Date:  2012-06-20       Impact factor: 3.616

6.  An early gene maps within and is 3' coterminal with the immediate-early gene of equine herpesvirus 1.

Authors:  R N Harty; D J O'Callaghan
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

7.  The three major immediate-early transcripts of bovine herpesvirus 1 arise from two divergent and spliced transcription units.

Authors:  U V Wirth; B Vogt; M Schwyzer
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  The extreme carboxyl terminus of the equine herpesvirus 1 homolog of herpes simplex virus VP16 is essential for immediate-early gene activation.

Authors:  G D Elliott
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Detection and intracellular localization of equine herpesvirus 1 IR1 and IR2 gene products by using monoclonal antibodies.

Authors:  G B Caughman; J B Lewis; R H Smith; R N Harty; D J O'Callaghan
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Identification and characterization of the ICP22 protein of equine herpesvirus 1.

Authors:  V R Holden; G B Caughman; Y Zhao; R N Harty; D J O'Callaghan
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.